Biofilm Dispersal and Wound Infection Clearance With Preclinical Debridement Agents
International Wound Journal · 2025
DOI: 10.1111/iwj.70145 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Wound Journal, 2025. Verfasst von Rebecca Elizabeth Schneider und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA. Hauptthemen laut MEDLINE: Biofilms, Debridement, Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, U.S. Department of Defense, NIH HHS.
Abstract (Originalsprache)
Biofilms complicate wound care by causing recurrent infections that are often resistant to debridement and are highly antibiotic‐tolerant. We investigated whether the addition of a biofilm dispersal agent could improve the efficacy of debridement. The previous studies have indicated that a glycoside hydrolase cocktail of alpha‐amylase and cellulase can act as a potent biofilm dispersal agent. With in vitro and ex vivo Pseudomonas aeruginosa biofilm models, we compared glycoside hydrolases against other, clinically relevant, enzymatic debridement agents (papain, bromelain, and collagenase). Glycoside hydrolase biofilm dispersal was dose‐dependent. However, at doses of 1% or above, glycoside hydrolases outperformed, or were comparable, to other enzymatic debridement agents. With our in vivo surgical wound infection model, we evaluated biofilm dispersal using infection dissemination as a proxy. We found that sharp debridement followed by multiple glycoside hydrolase treatments enhanced biofilm dispersal. Furthermore, a single dose of glycoside hydrolase in combination with debridement decreased infection load in acute wounds. Similarly, when we treated established 5‐day‐old infections, we saw a decrease in infection load and no infection dissemination. Overall, our data suggest that debridement enhances the efficacy of a topical antibiotic ointment, allowing for greater infection clearance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
- Department of Immunology and Molecular Microbiology, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
- Department of Chemistry and Biochemistry, Texas Tech University, Lubbock, Texas, USA.
ORCID-Profile: Rebecca Elizabeth Schneider
Förderung
- NIAID NIH HHS
- U.S. Department of Defense
- NIH HHS
- National Institutes of Health
Zitieren
APA
Schneider, R. E., Hamdan, J. V., & Rumbaugh, K. P. (2025). Biofilm Dispersal and Wound Infection Clearance With Preclinical Debridement Agents. International Wound Journal. https://doi.org/10.1111/iwj.70145
Vancouver
Schneider RE, Hamdan JV, Rumbaugh KP. Biofilm Dispersal and Wound Infection Clearance With Preclinical Debridement Agents. International Wound Journal. 2025. doi:10.1111/iwj.70145
BibTeX
@article{Schneider2025,
author = {Schneider, Rebecca Elizabeth and Hamdan, Jason Valentino and Rumbaugh, Kendra Pauline},
title = {Biofilm Dispersal and Wound Infection Clearance With Preclinical Debridement Agents},
journal = {International Wound Journal},
year = {2025},
doi = {10.1111/iwj.70145}
}
EUVIMED